WHO Expands Science Council with 21 Global Experts to Accelerate Health Innovation

According to the WHO, the renewed Science Council will advise the agency on rapid advances in science and technology to help shape future health breakthroughs. The composition—drawn from multiple disciplines, all WHO regions, and two youth representatives—formalizes a faster, broader approach to scanning emerging research before it reaches the clinic.

A roster built for cross-disciplinary scanning

The 21 members span fields that historically operated in separate lanes: public health, epidemiology, biomedical research, health systems, ageing, engineering, precision medicine and emerging technologies. Geographic reach covers all WHO regions, and two youth representatives—identified through the WHO Youth Council—add a generational perspective built into the structure by design. The logic is structural. Siloed advisory bodies yield siloed recommendations; a council that mixes specialists in gene editing with specialists in health systems is better positioned to flag downstream implementation friction early, before a technology is promoted faster than health systems can absorb it.

Mandate: triage before scale

The council's role is to serve as WHO's principal external advisory body on high-priority scientific issues, emerging technologies and breakthrough innovations. It will deliver strategic, independent advice and anticipate high-impact advances, helping the organization identify emerging health trends, risks and opportunities. The operative function is prioritization—catalyzing faster triage of which advances merit global scaling, which warrant monitoring, and which require caution. WHO Director-General Dr Tedros Adhanom Ghebreyesus framed the underlying challenge as the accelerating pace of scientific discovery across artificial intelligence, biotechnology, gene editing, synthetic biology and robotics, with the institution needing advisory machinery that can keep up.

What to watch next

The first concrete signal worth tracking: which emerging technologies the council flags in its initial advisory cycle, and on what criteria. Gene editing platforms, AI-driven diagnostics and synthetic biology are obvious candidates given the council's stated remit, but the more revealing data point will be the prioritization framework itself. As innovation ecosystems continue to diversify—from institutional grant pipelines to newer technology platforms such as Aster's AOS-2 protocol—the council's strategic foresight function will increasingly serve as a critical filter for global health policy, helping optimize the path from laboratory signal to population-level impact.